The metabolic syndrome identifies the clustering of lipid abnormalities, hypertension, hyperglycemia and abdominal obesity. It is a common and strong contributor to heart disease and diabetes and disproportionably affects older persons. Animal and small clinical studies have suggested that psychosocial stress is a risk factor for the metabolic syndrome. Underlying mechanisms may be through activation of the hypothalamopituitary-adrenal (HPA) axis causing hypercortisolemia, and, partly in turn, elevated inflammation and decreased sex hormone levels. However, longitudinal data showing that psychosocial stress indeed contributes to the onset and sequelae of the metabolic syndrome in the population at large, are lacking. We propose to conduct data-analyses and biological sample analyses to examine the effect of psychosocial stress, as indicated by mood problems (depressive symptoms) and stressful social circumstances (poverty, negative life events, occupational stress, lack of emotional support), on the onset and sequelae of the metabolic syndrome. Secondary objectives are to examine underlying biological mechanisms in the effect of psychosocial stress on the metabolic syndrome. We will use available data from two ongoing longitudinal community-based studies among older persons: the Health Aging and Body Composition (Health ABC) study (n=3,075, mean age=74 years, 52%=female, 42% African American) and the InChianti study (n=1,453, mean age=69 years, 56%=female). In both studies psychosocial stress and the metabolic syndrome are well defined, longitudinal data on sequelae (CVD events and diabetes onset) and onset of the metabolic syndrome are available, and potentially underlying biological variables were, or will be, assessed including 24-h urinary cortisol, serum sex steroid hormones (estradiol, testosterone, SHBG, DHEAS) and inflammatory markers (IL-6, IL-10, TNF-alpha, CRP, and various soluble cytokine receptors). The results of this study will help in designing future intervention trials that evaluate whether reducing stress and/or its physiological consequences, either by pharmacological treatment or behavioral intervention, could reduce incidence of the metabolic syndrome in the older general population.
| Vogelzangs, Nicole; Seldenrijk, Adrie; Beekman, Aartjan T F et al. (2010) Cardiovascular disease in persons with depressive and anxiety disorders. J Affect Disord 125:241-8 |
| Penninx, Brenda W J H; Nicklas, Barbara J; Newman, Anne B et al. (2009) Metabolic syndrome and physical decline in older persons: results from the Health, Aging And Body Composition Study. J Gerontol A Biol Sci Med Sci 64:96-102 |
| Maraldi, Cinzia; Harris, Tamara B; Newman, Anne B et al. (2009) Moderate alcohol intake and risk of functional decline: the Health, Aging, and Body Composition study. J Am Geriatr Soc 57:1767-75 |
| Vogelzangs, Nicole; Beekman, Aartjan T F; Dik, Miranda G et al. (2009) Late-life depression, cortisol, and the metabolic syndrome. Am J Geriatr Psychiatry 17:716-21 |
| Vogelzangs, Nicole; Kritchevsky, Stephen B; Beekman, Aartjan T F et al. (2008) Depressive symptoms and change in abdominal obesity in older persons. Arch Gen Psychiatry 65:1386-93 |
| Maraldi, Cinzia; Volpato, Stefano; Penninx, Brenda W et al. (2007) Diabetes mellitus, glycemic control, and incident depressive symptoms among 70- to 79-year-old persons: the health, aging, and body composition study. Arch Intern Med 167:1137-44 |
| Vogelzangs, Nicole; Suthers, Kristen; Ferrucci, Luigi et al. (2007) Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology 32:151-9 |
| Vogelzangs, Nicole; Penninx, Brenda W (2007) Cortisol and Insulin in Depression and Metabolic Syndrome. Psychoneuroendocrinology 32:856 |
